Technion - Israel Institute of Technology | GenomeWeb

Technion - Israel Institute of Technology

Researchers are developing a nanopore sensing device that relies on restriction enzymes to target specific clinically relevant variants in pathogens. 

Technion's Reut Shalgi is building up her lab to study how chaperones affect protein synthesis and protein folding.

The majority of the funding will be used to establish a cancer metabolomics research center on Technion's campus. 

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.